1083Comparative Evaluation of Two Different Investigational Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults
نویسندگان
چکیده
Meningococcal ABCWY Vaccine Formulations in Adolescents and Young Adults Stan L. Block, MD; Leszek Szenborn, MD; Wendy Daly, MD; Teresa Jackowska, MD; Vas Narasimhan, MD; Diego D’Agostino, MSc; Linda Han, MD; Peter M Dull, MD; Igor Smolenov, MD; Kentucky Pediatric and Adult Research Center, Bardstown, KY; Clinic of Pediatrics and Infectious Diseases, Wroclaw, Poland; Bluegrass Clinical Research Inc., Louisville, KY; Department of Pediatrics, Medical Center of Postgraduate Education, Warsaw, Poland; Novartis Vaccines and Diagnostics Inc., Cambridge, MA
منابع مشابه
1084Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents Xavier Saez-Llorens, MD; Diana Catalina Aguilera Vaca, MD; Katia Abarca, MD; Emmanuelle Maho, MSc; Linda Han, MD; Igor Smolenov, MD; Peter Dull, MD; Hospital del Niño, Panama City, Panama; Centro de Investigacion, Colombia, Colombia; Pontificia Universidad Catolica de Chile, Santiago, Chil...
متن کاملVaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults.
Vaccination programs employing capsular-based meningococcal vaccines have proved successful in a variety of settings globally since first introduced over 40 years ago. Similar successes have been demonstrated using meningococcal vaccines for use against serogroup B (MenB) outbreak strains but the diversity of MenB strains has limited vaccine use outside targeted geographic regions. MenB continu...
متن کاملSafety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.
BACKGROUND New vaccines containing highly conserved Streptococcus pneumoniae proteins such as pneumolysin toxoid (dPly) and histidine-triad protein D (PhtD) are being developed to provide broader protection against pneumococcal disease. This study evaluated the safety, reactogenicity and immunogenicity of different pneumococcal protein-containing formulations in adults. METHODS In a phase I d...
متن کاملPrevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania) was licensed for use among persons aged 11-55 years. CDCns Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of young adolescents (defined in this report as persons aged 11-12 years) with MCV4 at ...
متن کاملPrevention of meningococcal disease.
Invasive disease caused by Neisseria meningitidis has an average annual incidence of one case per 100,000 in the United States. The disease can be rapidly fatal or result in severe neurologic and vascular sequelae despite antibiotic therapy. Antibiotic chemoprophylaxis with rifampin, ciprofloxacin, or ceftriaxone is required for household and other close contacts. Although the majority of cases...
متن کامل